Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Recurrence”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Testing effectiveness (Phase 2)Ended earlyNCT01518933
What this trial is testing

Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted Patients

Who this might be right for
Hepatitis C Virus Recurrence
Rottapharm 20
Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Post-approval studies (Phase 4)Study completedNCT01134952
What this trial is testing

Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
London Health Sciences Centre 11
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Not applicableStudy completedNCT03665766
What this trial is testing

Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation

Who this might be right for
Liver Transplantation
Ain Shams University 126
Not applicableUnknownNCT04768517
What this trial is testing

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus (HIV) Coinfection
National Taiwan University Hospital 300
Not applicableStudy completedNCT00710801
What this trial is testing

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Who this might be right for
Hepatitis C Virus
University of Alberta 40
Post-approval studies (Phase 4)Study completedNCT04695769
What this trial is testing

Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

Who this might be right for
Chronic Hepatitis C
Helwan University 281
Not applicableStudy completedNCT02209675
What this trial is testing

Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation

Who this might be right for
Liver Disease
Ain Shams University 25
Not applicableUnknownNCT00213707
What this trial is testing

Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.

Who this might be right for
HCV Infection
University Hospital, Strasbourg, France 30
Not applicableActive Not RecruitingNCT04156945
What this trial is testing

Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men

Who this might be right for
Hepatitis C Virus Infection
Public Health Service of Amsterdam 258
Large-scale testing (Phase 3)Study completedNCT00469131
What this trial is testing

Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

Who this might be right for
Hepatitis CLiver Cirrhosis
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79
Post-approval studies (Phase 4)WithdrawnNCT02959359
What this trial is testing

DAA in the Risk of Recurrence After Curative Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
Post-approval studies (Phase 4)Study completedNCT00938860
What this trial is testing

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Who this might be right for
Hepatitis CLiver Transplantation
Novartis Pharmaceuticals 92
Testing effectiveness (Phase 2)Study completedNCT01938625
What this trial is testing

Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

Who this might be right for
Hepatitis C, Chronic
Janssen R&D Ireland 35
Large-scale testing (Phase 3)Ended earlyNCT00375895
What this trial is testing

Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Chronic Hepatitis CEvidence of Liver Transplantation
Rennes University Hospital 11
Not applicableUnknownNCT01473849
What this trial is testing

Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionHepatitis C
Sociedad Española de Trasplante Hepático 179
Not applicableStudy completedNCT03707080
What this trial is testing

Direct Acting Antiviral-Post Authorization Safety Study

Who this might be right for
Hepatitis CHepatocellular Carcinoma
Target PharmaSolutions, Inc. 42
Large-scale testing (Phase 3)Study completedNCT00151580
What this trial is testing

Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Liver TransplantationHepatitis C
Rennes University Hospital 200
Load More Results